Skip to main content
SpringerLink
Log in

Class-wide labelling changes tighten use of long-acting opioids

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • FDA. FDA announces safety labeling changes and postmarket study requirements for extended-release and long-acting opioid analgesics. Media Release : 10 Sep 2013. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Class-wide labelling changes tighten use of long-acting opioids. Reactions Weekly 1470, 3 (2013). https://doi.org/10.1007/s40278-013-5902-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-5902-8

Search

Navigation